Global Ablation Technology Market is valued at approximately USD 4 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11% over the forecast period 2020-2027. Ablation is minimally invasive procedures that involve the surgical removal of body tissues or biological material from human organs. Ablation procedures are gaining immense popularity around the world because they can be used in the treatment of several diseases, including cancer, cardiovascular, gynecology, and ophthalmology. Since ablation therapies are minimally invasive procedures therefore, it is less painful than traditional surgical operations, as well as have lesser recovery time. Therefore, these factors are expected to strengthen the demand for ablation technology around the world. Furthermore, rising incidences of cancer & cardiovascular diseases, a rise in demand for minimally invasive procedures, a growing elderly population, and the introduction of next-generation ablation technologies & products are the few factors responsible for the high CAGR of the market during the forecast period. As per the International Agency for Research on Cancer (IARC), nearly 17.0 million new cancer cases and 9.5 million cancer deaths were registered in 2018 around the world. Also, the global burden of cancer is expected to grow to almost 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. With the rise in the prevalence of cancer, the demand for ablation technologies is significantly growing all over the world. With the sudden outbreak of COVID-19 infections around the world, the apprehension associated with a shortage of vital life-saving devices and other crucial medical supplies is significantly increased, to prevent the spread of this pandemic and deliver optimum care. Therefore, there is an urgent need for ablation therapies, due to which market is likely to gain momentum in the forthcoming years. However, the high implementation cost of ablation technology, along with the unfavorable regulatory scenario are the few factors limiting the market growth over the forecast period of 2020-2027.

The regional analysis of the global Ablation Technology market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the growing awareness concerning treatments through using ablation technologies, coupled with the presence of well-established healthcare infrastructure in the region. Whereas, Asia-Pacific is also anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rising prevalence of cancer & cardiovascular diseases, growing aging population, and improving healthcare infrastructure would create lucrative growth prospects for the Ablation Technology market across the Asia-Pacific region.

Major market player included in this report are:
Medtronic PLC
Biosense Webster, Inc.
St. Jude Medical, Inc.
Boston Scientific Corporation
Angiodynamics, Inc.
Atricure, Inc.
Conmed Corporation
Olympus Corporation
Smith & Nephew
Galil Medical Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Radiofrequency Ablation
Laser/Light Ablation
Ultrasound Ablation
Electrical Ablation
Others

By Application:
Cardiovascular Disease Treatment
Cancer Treatment
Ophthalmologic Treatment
Orthopedic Treatment
Urological Treatment
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Ablation Technology Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors